Transaction allows Beckman to offer a more comprehensive range of research solutions to customers.

Beckman Coulter will acquire Dako Denmark’s research flow cytometry instrumentation business.

“We are enthusiastic about the opportunity to add Dako’s MoFlo XDP high-performance sorter, the gold standard for cell sorting, and the highly capable nine-color CyAn research flow cytometer to our existing portfolio of cytometry instruments. This transaction allows us to offer a more comprehensive range of research solutions to our customers,” says Scott Garrett, Beckman Coulter’s president and CEO.

According to Dako’s president and CEO, Patrik Dahlen, “This action reinforces our strategic intent to create a more focused business in anatomic pathology and tissue-based cancer diagnostics. We believe our flow cytometry instrumentation products are an excellent match for Beckman Coulter and will achieve even greater success when combined with the company’s existing flow cytometry infrastructure and reputation for quality, service, and support.”

Dako’s flow cytometry instrument business workforce of almost 200 people includes sales, marketing, research, manufacturing, and administrative personnel.

Previous articleGenelabs Technologies Regains Rights to Prestara in Japan
Next articleCancer’s Ability to Evade Immune System Illuminated